Teo Soleymani1, Soumya M Reddy2, Jeffrey M Cohen3, Andrea L Neimann4. 1. Department of Dermatology, Stanford University School of Medicine, 450 Broadway Street, Pavilion C, 2nd Floor, Redwood City, CA, 94063, USA. 2. Department of Medicine, Division of Rheumatology, NYU Psoriatic Arthritis Program, New York University School of Medicine, 333 E. 38th St., 4th floor, New York, NY, 10016, USA. 3. Ronald O. Perelman Department of Dermatology, NYU Langone Medical Center, New York University School of Medicine, 240 E. 38th Street, 11th Floor, New York, NY, 10016, USA. 4. Ronald O. Perelman Department of Dermatology, NYU Langone Medical Center, New York University School of Medicine, 240 E. 38th Street, 11th Floor, New York, NY, 10016, USA. Andrea.Neimann@nyumc.org.
Abstract
PURPOSE OF REVIEW: Diagnosis and treatment of psoriatic arthritis (PsA) can be challenging and require a multidisciplinary approach. This review provides an overview of combined dermatology-rheumatology clinics. RECENT FINDINGS: Combined dermatology-rheumatology clinics have emerged to optimize integrated care for patients with psoriasis and PsA. There are over 20 such clinics across the USA. These clinics facilitate multidisciplinary care for patients with psoriasis and PsA and have been found to improve outcomes and enhance both patient and physician satisfaction and knowledge. Challenges presented by these clinics include appropriate scheduling for both dermatologists and rheumatologists and proving the benefits of the clinics to obtain institutional support. Combined dermatology-rheumatology clinics are a novel model of care for patients with psoriasis and PsA. They improve outcomes, patient and physician satisfaction, and efficiency. As more of these clinics are established, we must further understand their impact on outcomes and care processes.
PURPOSE OF REVIEW: Diagnosis and treatment of psoriatic arthritis (PsA) can be challenging and require a multidisciplinary approach. This review provides an overview of combined dermatology-rheumatology clinics. RECENT FINDINGS: Combined dermatology-rheumatology clinics have emerged to optimize integrated care for patients with psoriasis and PsA. There are over 20 such clinics across the USA. These clinics facilitate multidisciplinary care for patients with psoriasis and PsA and have been found to improve outcomes and enhance both patient and physician satisfaction and knowledge. Challenges presented by these clinics include appropriate scheduling for both dermatologists and rheumatologists and proving the benefits of the clinics to obtain institutional support. Combined dermatology-rheumatology clinics are a novel model of care for patients with psoriasis and PsA. They improve outcomes, patient and physician satisfaction, and efficiency. As more of these clinics are established, we must further understand their impact on outcomes and care processes.
Authors: Axel Patrice Villani; Marie Rouzaud; Morgane Sevrain; Thomas Barnetche; Carle Paul; Marie-Aleth Richard; Marie Beylot-Barry; Laurent Misery; Pascal Joly; Michel Le Maitre; Selim Aractingi; François Aubin; Alain Cantagrel; Jean-Paul Ortonne; Denis Jullien Journal: J Am Acad Dermatol Date: 2015-06-06 Impact factor: 11.527
Authors: James G Krueger; Scott Fretzin; Mayte Suárez-Fariñas; Patrick A Haslett; Krista M Phipps; Gregory S Cameron; Juliet McColm; Artemis Katcherian; Inna Cueto; Traci White; Subhashis Banerjee; Robert W Hoffman Journal: J Allergy Clin Immunol Date: 2012-06-05 Impact factor: 10.793
Authors: L C Coates; T Aslam; F Al Balushi; A D Burden; Esther Burden-Teh; E Burden-The; A R Caperon; R Cerio; C Chattopadhyay; H Chinoy; M J D Goodfield; L Kay; S Kelly; B W Kirkham; C R Lovell; H Marzo-Ortega; N McHugh; R Murphy; N J Reynolds; C H Smith; E J C Stewart; R B Warren; R Waxman; H E Wilson; P S Helliwell Journal: Br J Dermatol Date: 2013-04 Impact factor: 9.302
Authors: Dafna D Gladman; Laura C Coates; Joseph Wu; Lara Fallon; Elizabeth D Bacci; Joseph C Cappelleri; Andrew G Bushmakin; Philip S Helliwell Journal: Arthritis Res Ther Date: 2022-02-09 Impact factor: 5.156